Clinical Trials Logo

Electroconvulsive Therapy clinical trials

View clinical trials related to Electroconvulsive Therapy.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04383509 Terminated - Depressive Episode Clinical Trials

Electroconvulsive Treatment Followed by Cognitive Control Training

ECT-CCT
Start date: May 10, 2020
Phase: N/A
Study type: Interventional

Major depressive disorder (MDD) is worldwide one of the most prevalent and disabling mental health conditions. Electroconvulsive therapy (ECT) is a safe and effective treatment even though 6-month relapse rates are high. Cognitive side effects of ECT, such as reduced cognitive control, might trigger mechanisms that increase relapse in patients. As such, cognitive control training (CCT) holds promise as a non-pharmacological strategy to improve long-term effects of ECT (i.e., increase remission, and reduce depression relapse).